XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Activities:    
Net income $ 150,922 $ 135,690
Adjustments to reconcile net income to net cash from operating activities:    
Credit loss expense 13,070 13,650
Deferred tax expense (benefit) (1,289) (4,446)
Accretion of loan discounts (7,888) (4,966)
Securities premium amortization (discount accretion), net 9,945 13,248
Net (gain) loss on securities transactions 14 0
Depreciation and amortization 21,894 20,236
Net (gain) loss on sale/write-down of assets/foreclosed assets (2,363) 91
Stock-based compensation 4,081 3,738
Net tax benefit from stock-based compensation 912 373
Earnings on life insurance policies (928) (909)
Net change in:    
Trading account securities (752) (3,558)
Lease right-of-use assets 6,390 6,220
Accrued interest receivable and other assets 55,711 331,765
Accrued interest payable and other liabilities (545,830) (22,698)
Net cash from operating activities (296,111) 488,434
Investing Activities:    
Securities held-to-maturity - Purchases (1,500) 0
Securities held to maturity: Maturities, calls and principal repayments 22,785 17,692
Securities available for sale:    
Purchases (5,902,064) (927,165)
Sales 38,556 0
Maturities, calls and principal repayments 4,199,617 2,134,363
Proceeds from sale of loans 605 300
Net change in loans (151,515) (566,638)
Benefits received on life insurance policies 687 129
Proceeds from sales of premises and equipment 5 4
Purchases of premises and equipment (40,953) (38,184)
Proceeds from sales of foreclosed assets 15,135 0
Net cash from investing activities (1,818,642) 620,501
Financing Activities:    
Net change in deposits (332,077) (1,114,082)
Net change in short-term borrowings 128,204 (156,981)
Proceeds from stock option exercises 3,708 2,915
Purchase of treasury stock (2,600) (2,073)
Cash dividends paid on preferred stock (1,669) (1,669)
Cash dividends paid on common stock (61,663) (59,804)
Net cash from financing activities (266,097) (1,331,694)
Net change in cash and cash equivalents (2,380,850) (222,759)
Cash and cash equivalents at beginning of period 10,234,258 8,687,276
Cash and cash equivalents at end of period $ 7,853,408 $ 8,464,517